CVS Health Corporation (NEO:CVS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 120.11 billion. The enterprise value is 214.97 billion.

Market Cap	120.11B
Enterprise Value	214.97B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.27B

Valuation Ratios

The trailing PE ratio is 19.44 and the forward PE ratio is 10.43.

PE Ratio	19.44
Forward PE	10.43
PS Ratio	0.23
PB Ratio	1.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 32.97.

EV / Earnings	34.79
EV / Sales	0.41
EV / EBITDA	9.19
EV / EBIT	16.67
EV / FCF	32.97

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.07.

Current Ratio	0.80
Quick Ratio	0.58
Debt / Equity	1.07
Debt / EBITDA	4.88
Debt / FCF	17.31
Interest Coverage	3.05

Financial Efficiency

Return on equity (ROE) is 5.88% and return on invested capital (ROIC) is 3.66%.

Return on Equity (ROE)	5.88%
Return on Assets (ROA)	2.29%
Return on Invested Capital (ROIC)	3.66%
Return on Capital Employed (ROCE)	5.69%
Revenue Per Employee	2.02M
Profits Per Employee	23,814
Employee Count	300,000
Asset Turnover	1.50
Inventory Turnover	19.88

Taxes

In the past 12 months, CVS Health has paid 2.74 billion in taxes.

Income Tax	2.74B
Effective Tax Rate	30.89%

Stock Price Statistics

The stock price has increased by +16.54% in the last 52 weeks. The beta is 0.59, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+16.54%
50-Day Moving Average	15.91
200-Day Moving Average	15.03
Relative Strength Index (RSI)	68.95
Average Volume (20 Days)	11,271

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.01

Income Statement

In the last 12 months, CVS Health had revenue of CAD 524.17 billion and earned 6.18 billion in profits. Earnings per share was 4.90.

Revenue	524.17B
Gross Profit	69.74B
Operating Income	12.74B
Pretax Income	8.86B
Net Income	6.18B
EBITDA	19.06B
EBIT	12.74B
Earnings Per Share (EPS)	4.90

Balance Sheet

The company has 19.33 billion in cash and 112.82 billion in debt, giving a net cash position of -93.49 billion.

Cash & Cash Equivalents	19.33B
Total Debt	112.82B
Net Cash	-93.49B
Net Cash Per Share	n/a
Equity (Book Value)	105.77B
Book Value Per Share	83.29
Working Capital	-25.25B

Cash Flow

In the last 12 months, operating cash flow was 10.32 billion and capital expenditures -3.80 billion, giving a free cash flow of 6.52 billion.

Operating Cash Flow	10.32B
Capital Expenditures	-3.80B
Free Cash Flow	6.52B
FCF Per Share	n/a

Margins

Gross margin is 13.30%, with operating and profit margins of 2.43% and 1.18%.

Gross Margin	13.30%
Operating Margin	2.43%
Pretax Margin	1.69%
Profit Margin	1.18%
EBITDA Margin	3.64%
EBIT Margin	2.43%
FCF Margin	1.24%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	74.62%
Buyback Yield	1.02%
Shareholder Yield	n/a
Earnings Yield	5.15%
FCF Yield	5.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	6